I-22nd Century Group imemezele izinhlelo zokuhlukanisa ingxenye enkulu yemisebenzi yayo ye-GVB Biopharma hemp/cannabis ku-Specialty Acquisition Corp., inkampani ehlobene nabasebenzi bakwa-GVB. Isivumelwano sibeka ukuthi inkampani izothola inkokhelo engu-$1 million uma sekuqediwe ukuthengisa, kanye nephepha lesithembiso elivikelwe elingamaphesenti angu-12 elifinyelela ku-$1.25 million kumthengi. Inkampani ihlose ukusebenzisa inzuzo ukuze iqhubeke yehlise izikweletu zayo zezimali.
Ngaphezu kwalokho, Iqembu le-22nd Century izogcina noma yiziphi izinkokhelo zomshwalense ezihlobene nesigameko somlilo endaweni yayo yokukhiqiza i-Grass Valley. Ingxenye yalezi zimali izosetshenziselwa ukumboza ingxenye yomthengi yezibopho ezabiwe.
Umsebenzi uhlelelwe ukuthi uphothulwe ekuqaleni kukaDisemba 2023, kusalindwe izimfuneko ezijwayelekile zokuvala, okuhlanganisa nokugunyazwa kwebhodi labaqondisi be-22nd Century.
Ukuhlukaniswa kwe-hemp yethu /insangu ukuhlukana kuzodambisa ngokuphawulekayo futhi ngokushesha izingcindezi zezezimali nezokusebenza ebhizinisini lethu.